Difference between revisions of "Part:BBa K320009"
Line 3: Line 3:
  
 
This BioBricks makes the bacteria resitance to Tetracycline, contain an origin of replication for Asaia/E.Coli and a constitutice expression of the protein P28.
 
This BioBricks makes the bacteria resitance to Tetracycline, contain an origin of replication for Asaia/E.Coli and a constitutice expression of the protein P28.
 +
 +
The ookinete (plasmodium state in mosquito's gut) has been intensively studied by scientists, looking for an ideal transmission-blocking vaccine target. IGEM EPFL team's interest goes toward the ookinete surface membrane proteins P25 and P28. In fact, it has been shown that the binding of specific antibodies to these surface proteins was fatal to more than 99% of the parasites [http://www.nature.com/emboj/journal/v20/n15/full/7593895a.html 2]. Indeed, P25 and P28 seem to be essential to the ookinete survival, the crossing of the midgut epithelium and its transformation into an oocyst.
 +
 +
The team decided to design Asaia to express a soluble form of these 2 P-proteins. It could seems contra-intuitive to provide more of these proteins (by expression in Asaia) that are very important for the parasite survival, migration, and development. But our hypothesis is that adding a lot of these proteins in a soluble form will compete with the parasite surface protein and prevent the interaction necessary to its transmission. Because the functions of P25 and P28 are redundant, both proteins need to be inhibited or outcompeted to efficiently block the malaria transmission.
  
 
<!-- Add more about the biology of this part here
 
<!-- Add more about the biology of this part here

Revision as of 19:40, 24 October 2010

Constitutive expression of P28 in Asaia and Resistance to Tetracycline

This BioBricks makes the bacteria resitance to Tetracycline, contain an origin of replication for Asaia/E.Coli and a constitutice expression of the protein P28.

The ookinete (plasmodium state in mosquito's gut) has been intensively studied by scientists, looking for an ideal transmission-blocking vaccine target. IGEM EPFL team's interest goes toward the ookinete surface membrane proteins P25 and P28. In fact, it has been shown that the binding of specific antibodies to these surface proteins was fatal to more than 99% of the parasites [http://www.nature.com/emboj/journal/v20/n15/full/7593895a.html 2]. Indeed, P25 and P28 seem to be essential to the ookinete survival, the crossing of the midgut epithelium and its transformation into an oocyst.

The team decided to design Asaia to express a soluble form of these 2 P-proteins. It could seems contra-intuitive to provide more of these proteins (by expression in Asaia) that are very important for the parasite survival, migration, and development. But our hypothesis is that adding a lot of these proteins in a soluble form will compete with the parasite surface protein and prevent the interaction necessary to its transmission. Because the functions of P25 and P28 are redundant, both proteins need to be inhibited or outcompeted to efficiently block the malaria transmission.

Sequence and Features


Assembly Compatibility:
  • 10
    COMPATIBLE WITH RFC[10]
  • 12
    INCOMPATIBLE WITH RFC[12]
    Illegal NheI site found at 62
  • 21
    COMPATIBLE WITH RFC[21]
  • 23
    COMPATIBLE WITH RFC[23]
  • 25
    INCOMPATIBLE WITH RFC[25]
    Illegal NgoMIV site found at 1934
    Illegal AgeI site found at 2094
  • 1000
    INCOMPATIBLE WITH RFC[1000]
    Illegal BsaI.rc site found at 772